Status:
COMPLETED
Does a Preoperative Prophylactic Antibiotic Reduce Surgical Site Infection Following Wire-localized Lumpectomy
Lead Sponsor:
CHU de Quebec-Universite Laval
Conditions:
Breast Cancer
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Background: Data on the benefits of preoperative prophylactic antibiotics for breast surgery are conflicting and there is no guideline for their use for wire-localized lumpectomy. The aims of this stu...
Eligibility Criteria
Inclusion
- \>18 years of age
- female
- scheduled for a wire-localized lumpectomy
Exclusion
- pregnant or breastfeeding women
- incapacity to give informed consent
- preoperative breast infection
- patients known to be colonized with MRSA
- immunocompromised patients
- preoperative antibiotic prophylaxis needed for any concomitant condition.
Key Trial Info
Start Date :
April 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2019
Estimated Enrollment :
326 Patients enrolled
Trial Details
Trial ID
NCT04818931
Start Date
April 7 2018
End Date
December 10 2019
Last Update
March 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Québec - Université Laval
Québec, Quebec, Canada, G1S4L8